Leading players in Spirometers Market

The spirometers market is expected to reach USD 1,047 million  by 2023 from USD 655 million in 2018, at a CAGR of 9.8%. Market growth is  largely driven by the rising global incidence of respiratory diseases, global  population, and technological advancements in spirometer devices. Opportunities  for growth of the market exist in emerging economies on account of increasing pollution  levels and rising awareness regarding COPD and other respiratory conditions. On   the other hand, the time required to carry out tests using spirometers and data  accuracy issues associated with personalized spirometers are expected to limit  market growth during the forecast period.
The spirometers market is highly consolidated in nature, with a few players offering a variety of products. The major players operating in this market are Hill Rom (US), Vyaire Medical (US), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (US), Medical International Research (Italy), NDD Medical Technologies (Switzerland), Vitalograph (UK), and MidMark Corporation (US).
The key strategies followed by most companies in the spirometers market are product launches and partnerships. These two strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2018.

Comments

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

Strategies Adopted by the Major Players in this Digital PCR Market

Sinus Dilation Devices Market Size And Share Report, 2027